<DOC>
	<DOCNO>NCT01813097</DOCNO>
	<brief_summary>Patients prostate cancer follow examination include biopsy , serum PSA volume , prostate CT scan MRI , bone scan , abdomen ultrasound , chest X ray , blood biochemistry , blood rout , ECG testosterone . Two group : First group:30 case treat iodine 125 seed implant 0.5 mc transperineal prostate implant +Zoladex 3.6mg im 1/28d ( LHRH agonist , 3.6mg subcutaneous injection 1/4weeks ) . Second group : 30 case treat Zoladex 3.6mg im 1/28d ( LHRH agonist , 3.6mg subcutaneous injection 1/4weeks ) . PFS PSA level primary variable .</brief_summary>
	<brief_title>Combination Iodine 125 Seed Implants LHRH Agonists Locally Advanced ( Stage T3 ) Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Iodine</mesh_term>
	<criteria>1 . Provision write informed consent 2 . T2cT3b N0 M0 ( biopsy、 bone scan、 CT、 MRI ) 3 . No Metastasis ( bone scan、 CT、 MRI ) 4 . PSA level &gt; 10ng/ml 5 . Histological cytological confirmation prostate cancer 6 . Able understand comply requirement study 1 . Having treat external radiation therapy chemistry therapy . 2 . Clinical relevant disease and/or abnormality ( past present ) , eg , significant cardiovascular , renal liver disease , malignancy , gastrointestinal disorder , condition could affect absorption/elimination drug . 3 . Alanine amino transferase ( ALT ) aspartate amino transferase ( AST ) great 2 time upper limit normal ( ULN ) screen finding make undesirable patient participate study opinion investigator ( ) 4 . In opinion investigator ( ) , evidence severe uncontrolled systemic disease ( eg , currently unstable unresolved respiratory , cardiac , hepatic , renal disease ) . 5 . Contraindications ( eg , know suspected allergy ) GnRH antagonists excipients ( nonactive ingredient investigational product ) . 6 . Treatment nonapproved investigational drug within 30 day study entry . 7 . Bibulosity drug abuse .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>To detective effect treatment combination iodine 125 seed implant LHRH agonists patient locally advanced prostate cancer .</keyword>
</DOC>